Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-gamma.
暂无分享,去创建一个
Theodore W Randolph | John F Carpenter | J. Carpenter | T. Randolph | J. Cleland | Serena D Webb | Jeffrey L Cleland | S. D. Webb
[1] Kai Griebenow,et al. Protein Spray-Freeze Drying. Effect of Atomization Conditions on Particle Size and Stability , 2000, Pharmaceutical Research.
[2] Michael J. Pikal,et al. Freeze‐Drying of Proteins. Process, Formulation, and Stability. , 1995 .
[3] M. Manning,et al. Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states. , 1996, Journal of pharmaceutical sciences.
[4] B. Chang,et al. Use of subambient thermal analysis to optimize protein lyophilization , 1992 .
[5] A. Klibanov,et al. Deterioration of lyophilized pharmaceutical proteins. , 1998, Biochemistry. Biokhimiia.
[6] L. Berg. pH changes in buffers and foods during freezing and subsequent storage , 1966 .
[7] S J Prestrelski,et al. Factors affecting short-term and long-term stabilities of proteins. , 2001, Advanced drug delivery reviews.
[8] S E Ealick,et al. Three-dimensional structure of recombinant human interferon-gamma. , 1991, Science.
[9] B. Chang,et al. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. , 1996, Journal of pharmaceutical sciences.
[10] J. Beijnen,et al. Pharmaceutical Development of (Investigational) Anticancer Agents for Parenteral Use-A Review , 1996 .
[11] J. Carpenter,et al. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization. , 2001, Journal of pharmaceutical sciences.
[12] J. May,et al. Determination of residual moisture in freeze-dried viral vaccines: Karl Fischer gravimetric and thermogravimetric methodologies. , 1982, Journal of biological standardization.
[13] M. Hageman,et al. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying. , 1999, Journal of pharmaceutical sciences.
[14] M. Pikal,et al. Intravial distribution of moisture during the secondary drying stage of freeze drying. , 1997, PDA journal of pharmaceutical science and technology.
[15] J L Cleland,et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.
[16] F. Franks. The Properties of Aqueous Solutions at Subzero Temperatures , 1982 .
[17] E. Gabellieri,et al. Proteins in frozen solutions: evidence of ice-induced partial unfolding. , 1996, Biophysical journal.
[18] M. Manning,et al. Infrared and circular dichroism spectroscopic characterization of structural differences between beta-lactoglobulin A and B. , 1996, Biochemistry.
[19] H. Susi,et al. Examination of the secondary structure of proteins by deconvolved FTIR spectra , 1986, Biopolymers.
[20] Chung C. Hsu,et al. Surface Denaturation at Solid-Void Interface—A Possible Pathway by Which Opalescent Participates Form During the Storage of Lyophilized Tissue-Type Plasminogen Activator at High Temperatures , 2004, Pharmaceutical Research.
[21] E. Teller,et al. ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS , 1938 .
[22] Michael J. Pikal,et al. Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice , 1997, Pharmaceutical Research.
[23] J. Carpenter,et al. The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. , 2001, Journal of pharmaceutical sciences.
[24] M. Pikal,et al. Effect of Initial Buffer Composition on pH Changes During Far-From-Equilibrium Freezing of Sodium Phosphate Buffer Solutions , 2004, Pharmaceutical Research.
[25] Steven L. Nail,et al. Measurement of Glass Transition Temperatures of Freeze-Concentrated Solutes by Differential Scanning Calorimetry , 2004, Pharmaceutical Research.
[26] M. Manning,et al. Aggregation of recombinant human interferon gamma: kinetics and structural transitions. , 1998, Journal of pharmaceutical sciences.
[27] M. Manning,et al. Spectroscopic study of secondary structure and thermal denaturation of recombinant human factor XIII in aqueous solution. , 1997, Archives of biochemistry and biophysics.
[28] Theodore W Randolph,et al. Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations. , 2002, Journal of pharmaceutical sciences.
[29] S J Prestrelski,et al. Biopharmaceutical powders: particle formation and formulation considerations. , 2000, Current pharmaceutical biotechnology.
[30] J. Carpenter,et al. A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20. , 2002, Journal of pharmaceutical sciences.
[31] W. Caughey,et al. Infrared methods for study of hemoglobin reactions and structures. , 1994, Methods in enzymology.
[32] A. I. Liapis,et al. ESTIMATION OF THE EFFECT OF PRODUCT SHRINKAGE ON THE DRYING TIMES, HEAT INPUT AND CONDENSER LOAD OF THE PRIMARY AND SECONDARY DRYING STAGES OF THE LYOPHILIZATION PROCESS IN VIALS , 1999 .